List of largest biotechnology & pharmaceutical companies
The following is a list of the top 25 independent biotechnology companies listed on a stock exchange (as indicated) ranked by market capitalization. Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.
Rankings
Rank[N 1] | Company | Largest Market Cap (USD billions) | Market Cap in Q2 2017 (USD billions) | Market Cap in 2016 (USD billions)[1][2] | Market Cap in 2015 (USD billions)[3] | Market Cap in 2014 (USD billions)[4] | Market Cap in 2013 (USD billions) |
---|---|---|---|---|---|---|---|
1 | Johnson & Johnson[P] NYSE: JNJ |
367.5 (June 2017) | 356.1 | 314.1 | 284.2 | 277.8 | 258.3 |
2 | Roche[P] OTCQX: RHHBY |
263.6 (Feb 2014) | 216.7 | 192.1 | 234.7 | 258.5 | 240.3 |
3 | Pfizer[P] NYSE: PFE |
310.5 (Jul 2000) | 200.5 | 196.3 | 199.3 | 205.4 | 196.0 |
4 | Novartis[P] NYSE: NVS |
275.2 (Jul 2015) | 197.5 | 170.5 | 206.1 | 229.8 | 195.0 |
5 | Merck & Co.[P] NYSE: MRK |
182.8 (Mar 2017) | 175.3 | 164.3 | 147.6 | 166.9 | 146.5 |
6 | AmgenB NASDAQ: AMGN |
134.5 (Mar 2017) | 126.7 | 108.9 | 122.5 | 93.1 | 78.7 |
7 | Sanofi[P] NYSE: SNY |
151.3 (Sep 2014) | 123.8 | 101.8 | 111.8 | 138.1 | 142.0 |
8 | AbbVie[P] NYSE: ABBV |
117.9 Jul 2015 | 115.4 | 100.2 | 96.8 | 104.1 | 83.8 |
9 9 | Novo Nordisk[P] NYSE: NVO |
159.6 (Aug 2015) | 109.4 | 92.6 | 153.9 | 125.4 | 19.6 |
10 1 | BayerB FWB: BAYN |
129.0 (Mar 2015) | 107.4 | 85.3 | 103.2 | 113.2 | 117.4 |
11 2 | GlaxoSmithKline[P] NYSE: GSK |
174.9 (May 2006) | 106.0 | 93.3 | 97.6 | 128.9 | 129.6 |
12 2 | CelgeneB NASDAQ: CELG |
110.0 Jul 2015 | 101.4 | 91.4 | 94.1 | 89.5 | 69.2 |
13 | Gilead SciencesB NASDAQ: GILD |
179.6 (Jun 2013) | 92.5 | 96.6 | 145.8 | 109.0 | 78.4 |
14 | Bristol-Myers Squibb[P] NASDAQ: BMY |
128.3 (Jul 2016) | 91.8 | 98.2 | 114.8 | 97.6 | 87.2 |
15 3 | Eli Lilly & Co[P] NYSE: LLY |
122.6 (Aug 2000) | 90.8 | 80.9 | 93.4 | 76.6 | 57.0 |
16 | AstraZeneca[P] NYSE: AZN |
102.9 (Oct 2006) | 86.3 | 68.8 | 85.8 | 88.9 | 74.6 |
17 | Abbott Laboratories[P] NYSE: ABT |
85.5 (June 2017) | 84.4 | 56.4 | 67.0 | 67.9 | 59.3 |
18 3 | Allergan[P] NYSE: AGN |
133.5 (Jul 2015) | 81.6 | 72.7 | 123.3 | 68.5 | 29.3 |
19 | Biogen[P] NASDAQ: BIIB |
111.7 (Mar 2015) | 57.6 | 61.6 | 68.3 | 79.7 | 66.1 |
20 2 | Regeneron Pharmaceuticals Inc[P] NASDAQ: REGN |
61.4 (Aug 2015) | 52.2 | 39.3 | 56.5 | 42.0 | 27.4 |
21 | Stryker Corporation[P] NYSE: SYK |
54.1 (June 2017) | 51.9 | 45.1 | 34.7 | 35.7 | 28.4 |
22 2 | Shire Pharmaceuticals[P] NASDAQ: SHPG |
62.0 (Sep 2014) | 50.0 | 50.1 | 41.0 | 42.4 | 28.1 |
23 | Teva Pharmaceutical[P] NYSE: TEVA |
60.4 (Jul 2015) | 33.8 | 37.5 | 55.9 | 49.0 | 37.8 |
24 | Vertex Pharmaceuticals[P] NASDAQ: VRTX |
34.6 (Aug 2015) | 32.1 | 18.3 | 31.0 | 28.7 | 17.4 |
25 | Zoetis[P] NASDAQ: ALXN |
31.2 (June 2017) | 30.6 | 26.4 | 23.8 | 21.6 | 16.3 |
Footnotes
- ↑ The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice-versa
Graphical representation
See also
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.